Tenon Medical, Inc. SEC filings TNON

Tenon Medical, Inc. has 300 filings in SEC EDGAR's recent list, going back to Oct 16, 2012. Its latest annual report, Form 10-K, was filed on Mar 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 22, 2026 (material agreement). The company's fiscal year ends on December 31.

Tenon Medical, Inc. SEC filings
Form Description Filed Period
8-K Current report
Material agreement
Oct 22, 2026 Oct 16, 2026
424B5 Prospectus supplement Oct 16, 2026 —
EFFECT Filing Oct 9, 2026 —
424B3 Prospectus Oct 9, 2026 —
S-3 Shelf registration Oct 5, 2026 —
D Filing Sep 21, 2026 —
8-K Current report
Material agreement, Unregistered share sale, Other events
Sep 16, 2026 Sep 11, 2026
8-K Current report
Other events
Sep 9, 2026 Sep 9, 2026
424B3 Prospectus Sep 8, 2026 —
EFFECT Filing Sep 4, 2026 —
D Filing Sep 4, 2026 —
S-3/A Amendment no. 2 to form s-3 Sep 2, 2026 —
8-K Current report
Material agreement, Unregistered share sale, Other events
Aug 31, 2026 Aug 27, 2026
8-K/A Amended current report
Material agreement, Unregistered share sale, Other events
Aug 26, 2026 Mar 11, 2026
8-K Current report
Other events
Aug 24, 2026 Aug 24, 2026
EFFECT Filing Aug 18, 2026 —
S-3/A Amendment no. 1 to form s-3 Aug 17, 2026 —
10-Q Quarterly report Aug 13, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 13, 2026 Aug 13, 2026
DEL AM Delaying amendment Aug 13, 2026 —
S-3 Shelf registration Aug 11, 2026 —
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
Aug 10, 2026 Aug 6, 2026
8-K Current report
Shareholder vote results
Jul 24, 2026 Jul 23, 2026
8-K Current report
Other events
Jul 20, 2026 Jul 17, 2026
DEFR14A Revised definitive proxy statement Jul 13, 2026 —
8-K Current report
Other events
Jul 10, 2026 Jul 10, 2026
8-K Current report
Material agreement, Other events
Jul 2, 2026 Jun 29, 2026
424B4 Prospectus Jun 30, 2026 —
EFFECT Filing Jun 29, 2026 —
S-1MEF Registration statement Jun 29, 2026 —
S-1/A Amended registration statement Jun 26, 2026 —
DEF 14A Proxy statement Jun 23, 2026 Jul 23, 2026
S-1 Registration statement Jun 22, 2026 —
S-3/A Amendment no. 1 to form s-3 Jun 22, 2026 —
8-K Current report
Material agreement, Officer or director change
Jun 12, 2026 Feb 26, 2026
PRE 14A Preliminary proxy statement Jun 12, 2026 Jun 12, 2026
8-K Current report
Bylaw or fiscal year change
Jun 11, 2026 Jun 10, 2026
DRS Filing May 29, 2026 —
8-K Current report
Listing notice
May 22, 2026 May 21, 2026
10-Q Quarterly report May 15, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 12, 2026 May 12, 2026
10-K Annual report Mar 27, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 19, 2026 Mar 19, 2026
D/A Filing Mar 19, 2026 —
D Filing Mar 18, 2026 —
8-K Current report
Material agreement, Unregistered share sale, Other events
Mar 17, 2026 Mar 11, 2026
8-K Current report
Listing notice
Feb 27, 2026 Feb 25, 2026
S-8 Employee stock plan registration Feb 12, 2026 —
8-K Current report
Results of operations, Other events
Feb 6, 2026 Feb 5, 2026
S-3 Shelf registration Dec 10, 2025 —
D Filing Nov 25, 2025 —
8-K Current report
Material agreement, Unregistered share sale, Other events
Nov 17, 2025 Nov 10, 2025
10-Q Quarterly report Nov 13, 2025 Sep 30, 2025
8-K/A Amended current report Oct 17, 2025 Aug 1, 2025
8-K Current report
Unregistered share sale
Oct 16, 2025 Oct 13, 2025
S-8 Employee stock plan registration Oct 10, 2025 —
8-K Current report
Shareholder vote results
Sep 23, 2025 Sep 18, 2025
DEFR14A Revised definitive proxy statement Sep 18, 2025 —
10-Q Quarterly report Aug 13, 2025 Jun 30, 2025
8-K Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Regulation FD disclosure
Aug 7, 2025 Aug 1, 2025
DEF 14A Proxy statement Jun 17, 2025 Jul 23, 2025
PRE 14A Preliminary proxy statement Jun 5, 2025 Jun 4, 2025
10-Q Quarterly report May 13, 2025 Mar 31, 2025
424B3 Prospectus Apr 16, 2025 —
EFFECT Filing Apr 15, 2025 —
CORRESP Letter to the SEC Apr 11, 2025 —
UPLOAD Letter from the SEC Apr 11, 2025 —
D Filing Apr 8, 2025 —
D Filing Apr 8, 2025 —
D Filing Apr 8, 2025 —
S-1 Registration statement Apr 4, 2025 —
8-K Current report
Material agreement, Unregistered share sale, Other events
Mar 28, 2025 Mar 25, 2025
8-K Current report
Material agreement, Unregistered share sale, Other events
Mar 27, 2025 Mar 25, 2025
424B5 Prospectus supplement Mar 27, 2025 —
10-K Annual report Mar 26, 2025 Dec 31, 2024
424B5 Prospectus supplement Mar 26, 2025 —
8-K Current report
Material agreement, Unregistered share sale
Mar 12, 2025 Mar 11, 2025
10-Q Quarterly report Nov 14, 2024 Sep 30, 2024
424B3 Prospectus Nov 12, 2024 —
EFFECT Filing Nov 8, 2024 —
CORRESP Letter to the SEC Nov 7, 2024 —
CORRESP Letter to the SEC Nov 4, 2024 —
S-1/A Amended registration statement Nov 4, 2024 —
UPLOAD Letter from the SEC Oct 25, 2024 —
S-1 Registration statement Oct 17, 2024 —
8-K Current report
Listing notice
Oct 4, 2024 Oct 3, 2024
8-K Current report
Material agreement, Regulation FD disclosure
Sep 17, 2024 Sep 12, 2024
8-K Current report
Material agreement, Unregistered share sale
Sep 16, 2024 Sep 16, 2024
424B4 Prospectus Sep 16, 2024 —
EFFECT Filing Sep 12, 2024 —
CORRESP Letter to the SEC Sep 12, 2024 —
CORRESP Letter to the SEC Sep 12, 2024 —
8-K Current report
Listing notice
Sep 11, 2024 Sep 9, 2024
8-K/A Amended current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change
Sep 10, 2024 Sep 5, 2024
S-1/A Amended registration statement Sep 9, 2024 —
S-1/A Amended registration statement Sep 9, 2024 —
8-K Current report
Material agreement, Agreement ended, Unregistered share sale
Sep 6, 2024 Sep 5, 2024
8-K Current report
Officer or director change, Other events
Aug 27, 2024 Aug 27, 2024
8-K Current report
Listing notice
Aug 26, 2024 Aug 23, 2024
UPLOAD Letter from the SEC Aug 22, 2024 —
S-1 Registration statement Aug 14, 2024 —
10-Q Quarterly report Aug 13, 2024 Jun 30, 2024
8-K Current report
Shareholder vote results
Jul 25, 2024 Jul 23, 2024
DEFR14A Filing Jul 15, 2024 —
DEFR14A Revised definitive proxy statement Jul 15, 2024 —
424B3 Prospectus Jul 10, 2024 —
424B3 Prospectus Jul 5, 2024 —
EFFECT Filing Jul 3, 2024 —
424B3 Prospectus Jul 3, 2024 —
424B3 Prospectus Jul 2, 2024 —
EFFECT Filing Jul 1, 2024 —
CORRESP Letter to the SEC Jul 1, 2024 —
EFFECT Filing Jun 25, 2024 —
S-1/A Amended registration statement Jun 21, 2024 —
POS AM Amendment no. 2 to pos am Jun 21, 2024 —
POS AM Post-effective amendment no. 1 to form s-1 Jun 21, 2024 —
CORRESP Letter to the SEC Jun 20, 2024 —
DEF 14A Proxy statement Jun 13, 2024 Jul 23, 2024
POS AM Post-effective amendment no. 1 to form s-1 Jun 12, 2024 —
PRE 14A Preliminary proxy statement Jun 3, 2024 Jul 23, 2024
UPLOAD Letter from the SEC May 29, 2024 —
8-K Current report
Officer or director change
May 22, 2024 May 20, 2024
10-Q Quarterly report May 15, 2024 Mar 31, 2024
S-1 Registration statement May 10, 2024 —
POS AM Post-effective amendment no. 1 to form s-1 May 10, 2024 —
8-K Current report
Listing notice
May 8, 2024 May 7, 2024
SC TO-I/A Tender offer statement May 7, 2024 —
SC TO-I Tender offer statement Apr 8, 2024 —
8-K Current report
Officer or director change, Other events
Apr 1, 2024 Mar 25, 2024
10-K Annual report Mar 29, 2024 Dec 31, 2023
8-K Current report
Results of operations
Mar 14, 2024 Mar 13, 2024
D Filing Feb 28, 2024 —
8-K Current report
Material agreement, Agreement ended, Unregistered share sale
Feb 22, 2024 Feb 20, 2024
8-K/A Amended current report
Shareholder vote results
Jan 31, 2024 Dec 21, 2023
8-K Current report
Listing notice
Jan 11, 2024 Jan 4, 2024
8-K/A Amended current report
Shareholder vote results, Other events
Jan 10, 2024 Dec 21, 2023
8-K Current report
Shareholder vote results, Other events
Dec 26, 2023 Dec 21, 2023
8-K Current report
Officer or director change
Dec 4, 2023 Nov 30, 2023
D Filing Dec 1, 2023 —
8-K Current report
Material agreement, Unregistered share sale
Nov 28, 2023 Nov 21, 2023
DEF 14A Proxy statement Nov 22, 2023 Dec 21, 2023
10-Q Quarterly report Nov 14, 2023 Sep 30, 2023
PRE 14A Preliminary proxy statement Nov 8, 2023 Nov 8, 2023
8-K Current report
Bylaw or fiscal year change, Other events
Nov 7, 2023 Nov 1, 2023
424B3 Prospectus Sep 22, 2023 —
EFFECT Filing Sep 21, 2023 —
CORRESP Letter to the SEC Sep 19, 2023 —
UPLOAD Letter from the SEC Sep 19, 2023 —
424B5 Prospectus supplement Sep 11, 2023 —
S-1 Registration statement Sep 11, 2023 —
424B5 Prospectus supplement Sep 8, 2023 —
8-K Current report
Auditor change
Sep 8, 2023 Sep 7, 2023
D Filing Aug 14, 2023 —
10-Q Quarterly report Aug 11, 2023 Jun 30, 2023
ARS Annual report to shareholders Aug 4, 2023 Dec 31, 2022
DEF 14A Proxy statement Aug 4, 2023 Sep 13, 2023
8-K Current report
Material agreement, Unregistered share sale
Jul 28, 2023 Jul 24, 2023
PRE 14A Preliminary proxy statement Jul 25, 2023 Sep 13, 2023
8-K Current report
Listing notice
Jul 21, 2023 Jul 20, 2023
8-K/A Amended current report Jul 18, 2023 Jun 14, 2023
8-K Current report
Listing notice
Jul 11, 2023 May 17, 2023
8-K Current report
Material agreement, Other events
Jun 20, 2023 Jun 14, 2023
424B4 Prospectus Jun 16, 2023 —
CERT Filing Jun 14, 2023 —
8-A12B Form 8a-12b Jun 14, 2023 —
EFFECT Filing Jun 13, 2023 —
S-1 Registration statement Jun 7, 2023 —
8-K Current report
Listing notice
May 19, 2023 May 17, 2023
EFFECT Filing May 17, 2023 —
CORRESP Letter to the SEC May 16, 2023 —
S-3/A Form s-3/a May 16, 2023 —
UPLOAD Letter from the SEC May 15, 2023 —
S-8 Employee stock plan registration May 9, 2023 —
10-Q Quarterly report May 9, 2023 Mar 31, 2023
S-3 Shelf registration May 4, 2023 —
DRS Filing Apr 24, 2023 —
10-K Annual report Mar 10, 2023 Dec 31, 2022
RW Form rw Feb 15, 2023 —
S-1/A Amended registration statement Feb 9, 2023 —
S-1 Registration statement Feb 8, 2023 —
DRS Filing Jan 13, 2023 —
S-8 Employee stock plan registration Nov 15, 2022 —
10-Q Quarterly report Nov 10, 2022 Sep 30, 2022
8-K Current report
Material agreement, Agreement ended, New debt, Other events
Oct 11, 2022 Oct 6, 2022
10-Q Quarterly report Aug 12, 2022 Jun 30, 2022
8-K Current report
Material agreement
Jul 27, 2022 Jul 21, 2022
10-Q Quarterly report Jun 9, 2022 Mar 31, 2022
8-K Current report
Results of operations, Regulation FD disclosure
Jun 7, 2022 Jun 7, 2022
8-K Current report
Regulation FD disclosure
May 31, 2022 May 31, 2022
8-K Current report
Material agreement, Other events
Apr 29, 2022 Apr 26, 2022
424B4 Prospectus Apr 27, 2022 —
CERT Filing Apr 27, 2022 —
EFFECT Filing Apr 26, 2022 —
8-A12B Form 8-a12b Apr 26, 2022 —
CORRESP Letter to the SEC Apr 25, 2022 —
CORRESP Letter to the SEC Apr 25, 2022 —
S-1/A Amended registration statement Apr 20, 2022 —
S-1/A Amended registration statement Apr 18, 2022 —
UPLOAD Letter from the SEC Apr 15, 2022 —
S-1/A Amended registration statement Apr 15, 2022 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
TNON (Nasdaq), TNONW (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Los Gatos, CA
SEC filer status
, Emerging growth company
SEC CIK
1560293

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.